Endogenex
Signal active
Organization
Contact Information
Overview
Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.
Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D.
About
Industries
Health Care, Medical Device, Therapeutics
Founded
2017
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Endogenex headquartered in United States, North America, operates in the Health Care, Medical Device, Therapeutics sector. The company focuses on Health Care and has secured $8.1B in funding across 72 round(s). With a team of 11-50 employees, Endogenex is actively contributing to advancements in Health Care. Their latest funding round, Series C - Endogenex, raised $88.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
7
Lead Investors
0
Total Funding Amount
$113.0M
Details
4
Endogenex has raised a total of $113.0M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | |||
| 2018 | Seed | 100.0K | ||
| 2018 | Seed | 140.0K | ||
| 2024 | Late Stage Venture | 88.0M |
Investors
Endogenex is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Mayo Clinic | - | FUNDING ROUND - Mayo Clinic | 88.0M |
| Orlando Health Ventures | - | FUNDING ROUND - Orlando Health Ventures | 88.0M |
| Endogenex | - | FUNDING ROUND - Endogenex | 88.0M |
| Intuitive Ventures | - | FUNDING ROUND - Intuitive Ventures | 88.0M |
Recent Activity
There is no recent news or activity for this profile.